Cytosorbents (CTSO) News Today → 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad) Free CTSO Stock Alerts $0.97 +0.10 (+11.69%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 1:38 AM | americanbankingnews.comCytosorbents Co. to Post Q2 2024 Earnings of ($0.09) Per Share, B. Riley Forecasts (NASDAQ:CTSO)May 18 at 3:56 AM | americanbankingnews.comCytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.comMay 17 at 6:08 AM | americanbankingnews.comCytosorbents (NASDAQ:CTSO) Stock Rating Reaffirmed by B. RileyMay 15, 2024 | finance.yahoo.comCTSO: CytoSorbents reports 1st quarter 2024 financial results and highlighted STAR-T trial data presentation at the AATS conference.May 15, 2024 | finance.yahoo.comCTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00May 12, 2024 | finance.yahoo.comCytosorbents First Quarter 2024 Earnings: In Line With ExpectationsMay 10, 2024 | finance.yahoo.comCytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call TranscriptMay 10, 2024 | americanbankingnews.comCytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.comMay 9, 2024 | globenewswire.comCytoSorbents Reports First Quarter 2024 ResultsMay 9, 2024 | markets.businessinsider.comHere's what Wall Street expects from Cytosorbents's earningsMay 7, 2024 | markets.businessinsider.comHold Rating on Cytosorbents Amid Regulatory Uncertainties and Mixed Clinical ResultsMay 2, 2024 | finance.yahoo.comCytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in EuropeApril 26, 2024 | globenewswire.comCytoSorbents to Report First Quarter 2024 Operating and Financial ResultsApril 17, 2024 | finance.yahoo.comSTAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual MeetingApril 4, 2024 | finance.yahoo.comCTSO: CytoSorbents Expects Significant Gross Margin Expansion in 2024.April 4, 2024 | finance.yahoo.comCTSO: CytoSorbents Expects Significant Gross Margin Expansion in 2023.March 16, 2024 | finance.yahoo.comCytosorbents Full Year 2023 Earnings: Misses ExpectationsMarch 16, 2024 | finance.yahoo.comCTSO Apr 2024 2.500 callMarch 15, 2024 | finance.yahoo.comQ4 2023 Cytosorbents Corp Earnings CallMarch 15, 2024 | finance.yahoo.comCytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | benzinga.comRecap: CytoSorbents Q4 EarningsMarch 14, 2024 | globenewswire.comCytoSorbents Reports Fourth Quarter and Full Year 2023 ResultsMarch 13, 2024 | markets.businessinsider.comCytosorbents earnings preview: what to expectMarch 6, 2024 | globenewswire.comCytoSorbents to Report Fiscal 2023 Operating and Financial ResultsMarch 4, 2024 | finance.yahoo.comCTSO Mar 2024 2.500 callFebruary 27, 2024 | money.usnews.comCytosorbents CorpFebruary 23, 2024 | finance.yahoo.comCytosorbents (NASDAQ:CTSO) investors are sitting on a loss of 90% if they invested three years agoFebruary 22, 2024 | benzinga.comCytoSorbents Stock (NASDAQ:CTSO) Insider TradesFebruary 22, 2024 | benzinga.comCytoSorbents Stock (NASDAQ:CTSO) Dividends: History, Yield and DatesFebruary 8, 2024 | finance.yahoo.comCytoSorbents to Present at the TD Cowen 44th Annual Health Care ConferenceJanuary 17, 2024 | finance.yahoo.comCTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.January 17, 2024 | finance.yahoo.comGroundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant PatientsJanuary 6, 2024 | stockhouse.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSODecember 30, 2023 | msn.comHC Wainwright & Co. Downgrades Cytosorbents (CTSO)December 30, 2023 | markets.businessinsider.comCytoSorbents Holds Steady with Neutral Rating Amid Clinical and Financial ReassessmentsDecember 29, 2023 | realmoney.thestreet.comCytoSorbents just downgraded at H.C. Wainwright, here's whyDecember 29, 2023 | markets.businessinsider.comWhat To Know About HC Wainwright & Co.'s Downgrade of CytoSorbentsDecember 28, 2023 | markets.businessinsider.comCytoSorbents: DrugSorb-ATR Study Fails To Meet Primary Effectiveness EndpointDecember 28, 2023 | finance.yahoo.comCytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board RecommendationDecember 18, 2023 | finance.yahoo.comInsider Spends US$100k Buying More Shares In CytosorbentsDecember 16, 2023 | finance.yahoo.comInsider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)December 13, 2023 | finance.yahoo.comCytoSorbents Announces Closing of $10.3 Million Registered Direct OfferingNovember 14, 2023 | finance.yahoo.comCTSO: CytoSorbents reports 3rd quarter 2023 financial and operating results which showed strong product revenue growth and an improved cost structure.November 12, 2023 | seekingalpha.comCytosorbents Corporation (CTSO) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | washingtonpost.comCytoSorbents: Q3 Earnings SnapshotNovember 9, 2023 | finance.yahoo.comCytoSorbents Reports Third Quarter 2023 Financial and Operational ResultsNovember 8, 2023 | markets.businessinsider.comHere's what Wall Street expects from Cytosorbents's earnings reportOctober 27, 2023 | finance.yahoo.comCytoSorbents to Report Third Quarter 2023 Operating and Financial ResultsOctober 5, 2023 | finance.yahoo.comCytoSorbents to Present at the 8th Annual Dawson James ConferenceSeptember 27, 2023 | finance.yahoo.comCytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address 4 Cryptos BETTER than Bitcoin (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 CTSO Media Mentions By Week CTSO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTSO News Sentiment▼0.370.42▲Average Medical News Sentiment CTSO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTSO Articles This Week▼71▲CTSO Articles Average Week Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LNSR News Today LUCD News Today CTCX News Today APYX News Today XAIR News Today AMIX News Today ICCM News Today DRIO News Today MODD News Today GBS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTSO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
